Patents by Inventor Antje Bruck

Antje Bruck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8663694
    Abstract: Taste masked dosage forms for oral administration of roflumilast are described.
    Type: Grant
    Filed: March 14, 2006
    Date of Patent: March 4, 2014
    Assignee: Takeda GmbH
    Inventors: Antje Brück-Scheffler, Alexander Pontius
  • Publication number: 20130237611
    Abstract: The invention relates to aqueous formulations containing (?)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl 4,4,4-trifluorobutane-1-sulfonate. Said formulations are suitable as infusion solutions or as concentrate for producing these infusion solutions.
    Type: Application
    Filed: April 26, 2013
    Publication date: September 12, 2013
    Applicant: Bayer Intellectual Property GmbH
    Inventors: Bernd Kühn, Antje Brück, Yoshifumi KATAKAWA, Masami YASUI
  • Publication number: 20110065788
    Abstract: The invention relates to aqueous formulations containing (?)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl 4,4,4-trifluorobutane-1-sulfonate. Said formulations are suitable as infusion solutions or as concentrate for producing these infusion solutions.
    Type: Application
    Filed: November 18, 2010
    Publication date: March 17, 2011
    Applicant: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
    Inventors: Bernd Kühn, Antje Brück, Yoshifumi Katakawa, Masami Yasui
  • Publication number: 20080193544
    Abstract: Taste masked dosage forms for oral administration of roflumilast are described.
    Type: Application
    Filed: March 14, 2006
    Publication date: August 14, 2008
    Applicant: Nycomed GmbH
    Inventors: Antje Bruck-Scheffler, Alexander Pontius
  • Publication number: 20060009420
    Abstract: The invention relates to aqueous formulations containing (?)-(R)-3-(2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluobutane-1-sulfonate. Said formulations are suitable as infusion solutions or as concentrate for producing these infusion solutions.
    Type: Application
    Filed: March 31, 2003
    Publication date: January 12, 2006
    Inventors: Bernd Kuhn, Antje Bruck, Yoshifumi Katakawa, Masami Yasui